These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8046403)

  • 1. Negatively cis-acting elements in the distal part of the promoter of Epstein-Barr virus trans-activator gene BZLF1.
    Schwarzmann F; Prang N; Reichelt B; Rinkes B; Haist S; Marschall M; Wolf H
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1999-2006. PubMed ID: 8046403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
    Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
    J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome.
    Le Roux F; Sergeant A; Corbo L
    J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the BZLF1 promoter of Epstein-Barr virus: identification of an anti-immunoglobulin response sequence.
    Shimizu N; Takada K
    J Virol; 1993 Jun; 67(6):3240-5. PubMed ID: 8388498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma cell-specific transcription factor XBP-1s binds to and transactivates the Epstein-Barr virus BZLF1 promoter.
    Sun CC; Thorley-Lawson DA
    J Virol; 2007 Dec; 81(24):13566-77. PubMed ID: 17898050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product.
    Adamson AL; Kenney SC
    Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
    Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
    Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C-independent activation of the Epstein-Barr virus lytic cycle.
    Gradoville L; Kwa D; El-Guindy A; Miller G
    J Virol; 2002 Jun; 76(11):5612-26. PubMed ID: 11991990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activity.
    Chen H; Lee JM; Wang Y; Huang DP; Ambinder RF; Hayward SD
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9339-44. PubMed ID: 10430944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemopreventive compound curcumin is an efficient inhibitor of Epstein-Barr virus BZLF1 transcription in Raji DR-LUC cells.
    Hergenhahn M; Soto U; Weninger A; Polack A; Hsu CH; Cheng AL; Rösl F
    Mol Carcinog; 2002 Mar; 33(3):137-45. PubMed ID: 11870879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the BZLF1 promoter of Epstein-Barr virus by second messengers in anti-immunoglobulin-treated B cells.
    Daibata M; Speck SH; Mulder C; Sairenji T
    Virology; 1994 Feb; 198(2):446-54. PubMed ID: 8291228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BZLF1 promoter of Epstein-Barr virus is controlled by E box-/HI-motif-binding factors during virus latency.
    Thomas C; Dankesreiter A; Wolf H; Schwarzmann F
    J Gen Virol; 2003 Apr; 84(Pt 4):959-964. PubMed ID: 12655097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of the BZLF1 promoter of Epstein-Barr virus.
    Montalvo EA; Shi Y; Shenk TE; Levine AJ
    J Virol; 1991 Jul; 65(7):3647-55. PubMed ID: 1645787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone acetylation and reactivation of Epstein-Barr virus from latency.
    Jenkins PJ; Binné UK; Farrell PJ
    J Virol; 2000 Jan; 74(2):710-20. PubMed ID: 10623733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of ZIIBC, a complex formed by cellular factors and the ZII site of the Epstein-Barr virus BZLF1 promoter.
    Ruf IK; Rawlins DR
    J Virol; 1995 Dec; 69(12):7648-57. PubMed ID: 7494273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.
    Speck SH; Chatila T; Flemington E
    Trends Microbiol; 1997 Oct; 5(10):399-405. PubMed ID: 9351176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of oriLyt, the lytic origin of DNA replication of Epstein-Barr virus, by BZLF1.
    Schepers A; Pich D; Hammerschmidt W
    Virology; 1996 Jun; 220(2):367-76. PubMed ID: 8661388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activators of the Epstein-Barr virus lytic program concomitantly induce apoptosis, but lytic gene expression protects from cell death.
    Inman GJ; Binné UK; Parker GA; Farrell PJ; Allday MJ
    J Virol; 2001 Mar; 75(5):2400-10. PubMed ID: 11160743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.